Ad
related to: what is desenex used for in adults symptoms
Search results
Results From The WOW.Com Content Network
Guanfacine, sold under the brand name Tenex (immediate-release) and Intuniv (extended-release) among others, is an oral alpha-2a agonist medication used to treat attention deficit hyperactivity disorder (ADHD) and high blood pressure.
Clotrimazole, sold under the brand name Lotrimin, among others, is an antifungal medication. [2] It is used to treat vaginal yeast infections, oral thrush, diaper rash, tinea versicolor, and types of ringworm including athlete's foot and jock itch. [2]
Medically unexplained physical symptoms (MUPS or MUS) are symptoms for which a treating physician or other healthcare providers have found no medical cause, or whose cause remains contested. [1] In its strictest sense, the term simply means that the cause for the symptoms is unknown or disputed—there is no scientific consensus .
Anticholinergic drugs are used to treat a variety of conditions: Dizziness (including vertigo and motion sickness-related symptoms) Extrapyramidal symptoms, a potential side-effect of antipsychotic medications; Gastrointestinal disorders (e.g., peptic ulcers, diarrhea, pyloro spasm, diverticulitis, ulcerative colitis, nausea, and vomiting)
MCS is generally used to refer to more significant disability. [5] The name has also been criticized because it suggests that chemical exposure is the actual cause or etiology, which has not been proven. The word chemical in the name is used loosely and includes natural substances (e.g., the aromas produced by pine trees or other fragrant ...
Older adults are prone to dehydration for many reasons. Learn how to identify the symptoms of dehydration in older adults based on how they look and feel.
Plus, how older adults can protect themselves.
The number of people with PNES ranges from 2 to 33 per 100,000. [6] PNES are most common in young adults, particularly women. [6] The prevalence for PNES is estimated to make up 5–20% of outpatient epilepsy clinics; 75–80% of these diagnoses are given to female patients and 83% are to individuals between 15 and 35 years old.